The Milwaukee Journal Sentinel (9/10, Fauber, Wynn, Fiore) reports that “since 2013, there have been more than 19,000 reports of complications from AD/HD” medications “made to the U.S. Food and Drug Administration, according to a Milwaukee Journal Sentinel/MedPage Today analysis.” The article points out that “in the case of adult AD/HD, the definition was relaxed in 2013 by the American Psychiatric Association.”
According to “the new definition, adults need to have five of a possible nine symptoms from either of two categories, down from six of a possible nine, and the symptoms must have been present before age 12, instead of the previous age 7.” However, some “experts question whether adult AD/HD truly is a widespread condition that needs treatment with dangerous” medications.
Related Links:
— “Abuse of ADHD drugs following path of opioids,” John Fauber, Matthew Wynn and Kristina Fiore, Milwaukee Journal Sentinel, September 10, 2016.